{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:41:21Z","timestamp":1760028081947,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.jacc.2016.11.054","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T15:45:42Z","timestamp":1486395942000},"page":"625-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents"],"prefix":"10.1016","volume":"69","author":[{"given":"David J.","family":"Moliterno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled M.","family":"Ziada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2016.11.054_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A\u00a0prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.11.054_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2016.11.055","article-title":"10-year clinical outcome after randomization to treatment by sirolimus- or paclitaxel-eluting coronary stents","volume":"69","author":"Gall\u00f8e","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.054_bib3","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/eurheartj\/ehw343","article-title":"Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial","volume":"37","author":"Yamaji","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2016.11.054_bib4","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2015.05.051","article-title":"10-year mortality outcome of a routine invasive strategy versus a selective invasive strategy in non-ST-segment elevation acute coronary syndrome: the British Heart Foundation RITA-3 Randomized Trial","volume":"66","author":"Henderson","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.054_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jacc.2006.11.048","article-title":"The final 10-year follow-up results from the BARI randomized trial","volume":"49","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.054_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2016.11.054_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/14017431.2014.883461","article-title":"Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents","volume":"48","author":"Bligaard","year":"2014","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.jacc.2016.11.054_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jcin.2009.10.003","article-title":"Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)","volume":"2","author":"Ellis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.11.054_bib9","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jacc.2009.01.050","article-title":"Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial","volume":"53","author":"Weisz","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2016.11.054_bib10","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2016.11.054_bib11","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2016.11.054_bib12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971637334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971637334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:12:53Z","timestamp":1760015573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971637334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S073510971637334X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.054","relation":{},"ISSN":["0735-1097"],"issn-type":[{"type":"print","value":"0735-1097"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2016.11.055","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}